8-K
Current Report
CNS Pharmaceuticals, Inc. Filed Acc 0001683168-24-000660
Material agreement · Executive or director change
- Item 1.01 Entry into a material definitive agreement
- Item 5.02 Departure or appointment of directors or officers
From the SEC's structured data for this filing
Loading cns_8k.htm…